A. Enrique Caballero, MD
A. Enrique Caballero, MD, is an endocrinologist, clinical investigator and teacher/educator at Harvard Medical School. He is the director of International Innovation Programs in the Office for External Education and the director of Diabetes Education in the Postgraduate Medical Education Department at Harvard Medical School, where he leads the development of educational programs that benefit health care professionals and patients around the world. Dr. Caballero is also the director of Latino Diabetes Health in the Division of Endocrinology, Diabetes and Hypertension and an associate scientist in the Division of Global Health Equity at Brigham and Women’s Hospital. He is also an associate professor of medicine at Harvard Medical School.
Dr. Caballero has had a strong and long commitment to helping underserved populations. He founded the Latino Diabetes Initiative at the Joslin Diabetes Center and the Diabetes Program within the Spanish Clinic at Brigham and Women’s, both affiliated with Harvard Medical School. He is currently the director of Latino Diabetes Health in the Division of Endocrinology at Brigham and Women’s.
Dr. Caballero has been actively involved in multiple activities aiming at eliminating health care disparities through national and international organizations such as the American Diabetes Association, the Endocrine Society, the National Hispanic Medical Association, the National Minority Quality Forum, the American Association of Clinical Endocrinologists, the Latin American Diabetes Association, and the International Diabetes Federation among others. He is also the immediate past chair of the Health Care Disparities Committee at the American Diabetes Association.
Through multiple activities in the areas of patient care, patient education, community outreach, clinical research and professional education, Dr. Caballero’s work has favorably impacted the lives of thousands of people and families with diabetes or at risk for the disease.
Dr. Caballero’s research interests include type 2 diabetes and cardiovascular disease prevention, as well as the management of diabetes in racial/ethnic minorities. He has been a co-investigator of the National Diabetes Prevention Program, the Look AHEAD Program and the Diabetes Education Study, all sponsored by the National Institutes of Health.
Dr. Caballero has written numerous publications on how diabetes affects the Latino/Hispanic community, diabetes management and prevention, obesity and the link between diabetes and cardiovascular disease. He is also an editor and reviewer for multiple prestigious medical journals.
Dr. Caballero has received local, regional, national and international recognitions and awards. He is the recipient of the 2009 “Alberto Houssay” award by the National Minority Quality Forum, the 2011 award by the American Association of Clinical Endocrinologists for his work on health care disparities and with underserved populations, and the 2012 Distinguished Community Service and Leadership Award by ALPFA Health Care. In addition, Dr. Caballero was recently named an honorary member of the Dominican Republic Endocrinology and Nutrition Society for his contributions to the Hispanic/Latino community. He also received special recognition from the government of Mexico for his continuous effort and commitment to helping underserved populations. Lastly, he is the 2022 recipient of the prestigious Harold Amos award given by Harvard Medical School as a recognition of his contributions to diversity, equity and inclusion in health care.
Dr. Caballero graduated from the National University of Mexico Medical School, where he was awarded the “Gabino Barreda” medal for being the top student and achieving the highest academic level in his class. He then completed his residency in Internal Medicine at the PEMEX hospital and his fellowship in Endocrinology at the National Institute of Nutrition in Mexico and went on to complete a master’s degree in Clinical Epidemiology in Mexico. In addition, Dr. Caballero completed a fellowship program in Endocrinology and Metabolism at the Lahey Clinic/Deaconess Hospital/Joslin Diabetes Center in Boston and the Program on Clinical Effectiveness at the Harvard School of Public Health.